Insider Transactions in Q3 2021 at Axogen, Inc. (AXGN)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2021
|
Karen L. Zaderej CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
46,500
+5.08%
|
$139,500
$3.67 P/Share
|
|
Aug 12
2021
|
Karen L. Zaderej CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,254
+0.99%
|
$41,270
$5.09 P/Share
|
|
Aug 10
2021
|
Karen L. Zaderej CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+8.06%
|
$375,000
$5.09 P/Share
|
|
Aug 06
2021
|
Karen L. Zaderej CEO |
SELL
Open market or private sale
|
Direct |
41,000
-1.22%
|
$738,000
$18.79 P/Share
|
|
Jul 21
2021
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
1,935
-4.52%
|
$38,700
$20.04 P/Share
|
|
Jul 20
2021
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
637
-3.76%
|
$12,103
$19.2 P/Share
|
|
Jul 20
2021
|
Maria D. Martinez Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
637
-11.57%
|
$12,103
$19.2 P/Share
|
|
Jul 20
2021
|
Isabelle Billet Chief Strategy and BD Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
728
-5.17%
|
$13,832
$19.2 P/Share
|
|
Jul 20
2021
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
918
-4.18%
|
$17,442
$19.2 P/Share
|
|
Jul 20
2021
|
Angelo Scopelianos Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
637
-5.92%
|
$12,103
$19.2 P/Share
|
|
Jul 20
2021
|
Eric Sandberg Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,090
-14.28%
|
$20,710
$19.2 P/Share
|
|
Jul 20
2021
|
Karen L. Zaderej CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,812
-1.12%
|
$167,428
$19.2 P/Share
|
|
Jul 20
2021
|
Michael Patrick Donovan VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
637
-1.47%
|
$12,103
$19.2 P/Share
|
|
Jul 20
2021
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
392
-0.49%
|
$7,448
$19.2 P/Share
|
|
Jul 19
2021
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
BUY
Grant, award, or other acquisition
|
Direct |
2,572
+13.18%
|
-
|
|
Jul 19
2021
|
Maria D. Martinez Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,572
+31.85%
|
-
|
|
Jul 19
2021
|
Isabelle Billet Chief Strategy and BD Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,572
+15.44%
|
-
|
|
Jul 19
2021
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,710
+14.46%
|
-
|
|
Jul 19
2021
|
Angelo Scopelianos Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,572
+19.3%
|
-
|
|
Jul 19
2021
|
Eric Sandberg Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,408
+36.61%
|
-
|
|
Jul 19
2021
|
Karen L. Zaderej CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,077
+2.72%
|
-
|
|
Jul 19
2021
|
Michael Patrick Donovan VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,572
+5.59%
|
-
|
|
Jul 19
2021
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,580
+1.92%
|
-
|